AMICUS THERAPEUTICS, INC. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMICUS THERAPEUTICS, INC. for March 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2015 | FOLD | AMICUS THERAPEUTIC ... | Do Hung | Sr Vice President D ... | Sell | D | 10.84 | 41,441 | 449,307 | 787,399 | 828.8 K to 787.4 K (-5.00 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.52 | 3,500 | 8,820 | 26,500 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 5.33 | 2,000 | 10,650 | 0 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 0.64 | 543 | 346 | 0 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 12.11 | 1,708 | 20,684 | 50,000 | 51.7 K to 50 K (-3.30 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 11.68 | 6,043 | 70,555 | 51,708 | 57.8 K to 51.7 K (-10.46 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 11.68 | 6,043 | 70,555 | 57,751 | 51.7 K to 57.8 K (+11.69 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 2.45 | 5,611 | 13,747 | 39,389 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 2.52 | 715 | 1,802 | 9,026 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Option Exercise | M | 3.53 | 1,459 | 5,150 | 8,341 | |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Sell | S | 11.51 | 7,785 | 89,585 | 50,000 | 57.8 K to 50 K (-13.47 %) |
Mar 25 2015 | FOLD | AMICUS THERAPEUTIC ... | Yu Julie | VP Clinical Ops & D ... | Buy | M | 11.51 | 7,785 | 89,585 | 57,785 | 50 K to 57.8 K (+15.57 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 47,500 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.52 | 5,000 | 12,600 | 30,000 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Option Exercise | M | 2.81 | 550 | 1,546 | 0 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Sell | S | 11.53 | 13,050 | 150,500 | 50,000 | 63.1 K to 50 K (-20.70 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | VP, Pharmacology & ... | Buy | M | 11.53 | 13,050 | 150,500 | 63,050 | 50 K to 63.1 K (+26.10 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.45 | 5,000 | 12,250 | 45,000 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 2.52 | 2,500 | 6,300 | 22,292 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 3.53 | 2,500 | 8,825 | 18,647 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 11.52 | 10,000 | 115,160 | 50,000 | 60 K to 50 K (-16.67 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 11.52 | 10,000 | 115,160 | 60,000 | 50 K to 60 K (+20.00 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Option Exercise | M | 6.06 | 10,110 | 61,267 | 24,890 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Sell | S | 11.51 | 10,110 | 116,359 | 50,000 | 60.1 K to 50 K (-16.82 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Kirk John | VP, Regulatory Affa ... | Buy | M | 11.51 | 10,110 | 116,359 | 60,110 | 50 K to 60.1 K (+20.22 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 42,188 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 2.52 | 3,462 | 8,724 | 31,538 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Option Exercise | M | 3.53 | 4,374 | 15,440 | 30,626 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Sell | S | 11.51 | 10,648 | 122,568 | 50,000 | 60.6 K to 50 K (-17.56 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | VP, Patient Advocac ... | Buy | M | 11.51 | 10,648 | 122,568 | 60,648 | 50 K to 60.6 K (+21.30 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 42,188 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 2.52 | 3,463 | 8,727 | 31,537 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 3.53 | 2,624 | 9,263 | 25,376 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 4.38 | 1,896 | 8,304 | 33,104 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Option Exercise | M | 4.16 | 3,250 | 13,520 | 9,750 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Sell | S | 11.51 | 14,045 | 161,669 | 50,000 | 64 K to 50 K (-21.93 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Dilone Enrique | VP, Technical Opera ... | Buy | M | 11.51 | 14,045 | 161,669 | 64,045 | 50 K to 64 K (+28.09 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.33 | 268,322 | 1,428,815 | 0 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 11.49 | 268,322 | 3,082,242 | 83,499 | 351.8 K to 83.5 K (-76.27 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 11.49 | 268,322 | 3,082,242 | 351,821 | 83.5 K to 351.8 K (+321.35 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 2.81 | 416 | 1,169 | 19,584 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Option Exercise | M | 4.16 | 12,583 | 52,345 | 25,167 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Sell | S | 11.51 | 12,999 | 149,595 | 200,000 | 213 K to 200 K (-6.10 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 11.51 | 416 | 4,787 | 212,999 | 212.6 K to 213 K (+0.20 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Campbell Bradley L | Chief Operating Off ... | Buy | M | 11.51 | 12,583 | 144,808 | 212,583 | 200 K to 212.6 K (+6.29 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.45 | 7,500 | 18,375 | 82,500 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 2.52 | 2,655 | 6,691 | 51,534 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Option Exercise | M | 3.53 | 5,080 | 17,932 | 48,420 | |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Sell | S | 11.51 | 15,235 | 175,294 | 100,000 | 115.2 K to 100 K (-13.22 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 7,500 | 86,295 | 115,235 | 107.7 K to 115.2 K (+6.96 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 2,655 | 30,548 | 107,735 | 105.1 K to 107.7 K (+2.53 %) |
Mar 24 2015 | FOLD | AMICUS THERAPEUTIC ... | Baird William D III | Chief Financial Off ... | Buy | M | 11.51 | 5,080 | 58,450 | 105,080 | 100 K to 105.1 K (+5.08 %) |